Personal care company Edgewell Personal Care (NYSE: EPC) missed Wall Street’s revenue expectations in Q2 CY2026 as sales only rose 1.7% year on year to $570.1 million. Its non-GAAP profit of $0.72 per share was 17.6% above analysts’ consensus estimates.

Is now the time to buy EPC? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Edgewell Personal Care's second quarter saw a positive market reaction despite missing Wall Street’s revenue expectations, as management highlighted improved execution in North America and gains across key brands such as Hawaiian Tropic and Cremo. CEO Rod Little attributed the progress to a focused investment behind global brands and the benefits of organizational simplification following the divestiture of the Feminine Care business. The quarter also reflected the initial benefits of a major manufacturing consolidation, although temporary supply chain disruptions weighed on private label and international performance.

Looking ahead, management’s guidance is grounded in expectations for further growth in both North America and international markets, with a particular focus on productivity initiatives and brand innovation. CFO Francesca Weissman emphasized that gross margin expansion is anticipated in the coming quarter, largely due to productivity gains and cycling of last year’s one-time costs. Management believes that ongoing investments in technology and capabilities, as well as increased advertising for key brands, will strengthen Edgewell’s competitive positioning into next year.

Key Insights from Management’s Remarks

Management pointed to brand-focused investments, supply chain transitions, and strategic simplification as the cornerstone themes shaping recent performance and future outlook.

• Brand investment ramp-up: Edgewell increased advertising and promotional spend, launching new campaigns for Schick, Billie, and Cremo, and advancing its Hawaiian Tropic campaign into its second year, aiming to build long-term value and consumer engagement.
• Manufacturing consolidation impact: The company's largest operational initiative since 2015—a consolidation of Wet Shave manufacturing—temporarily disrupted supply for private label products, particularly in European and Latin American markets. Management expects these issues to subside as network efficiency improves.
• Portfolio simplification benefits: Following the divestiture of the Feminine Care segment, Edgewell allocated more resources toward its highest-return brand opportunities, allowing for greater focus and increasing the share of investment behind global brands.
• North American growth momentum: Commercial execution and expanded distribution in North America led to double-digit Grooming growth and mid-single-digit gains in Sun and Skin categories. Cremo achieved its seventh consecutive quarter of over 20% growth in Grooming, and Hawaiian Tropic rose to become the #4 brand in Sun Care.
• Operational transformation underway: Edgewell accelerated initiatives to streamline its organization and cost structure, investing in analytics and AI-enabled tools to improve decision-making and productivity. These measures are intended to drive sustainable growth and profitability, offsetting inflation and external pressures.

Drivers of Future Performance

Edgewell’s forward guidance is shaped by continued investment in brand innovation, operational efficiency, and the expectation of improving margins as supply chain disruptions ease.

• Productivity and margin expansion: Management expects significant gross margin growth in the upcoming quarter, driven by productivity initiatives, reduced costs following the Feminine Care exit, and the maturation of the manufacturing consolidation project. However, commodity inflation, particularly oil, remains an external risk.
• Brand innovation pipeline: The company plans to sustain momentum with new product launches and refreshed campaigns, such as a major packaging update for Banana Boat and further innovation for Billie, which management believes will help capture market share and drive category growth.
• Category and macroeconomic headwinds: While North America and international markets are forecast to grow, management acknowledged the potential for slower category growth, increased competition, and volatility in consumer demand, which will require disciplined planning and execution.

Catalysts in Upcoming Quarters

Looking ahead, our analysts will closely track (1) the stabilization and growth of international sales as supply chain issues resolve, (2) the effectiveness of new product launches and brand campaigns—especially for Banana Boat and Billie, and (3) the realization of margin expansion through productivity initiatives and operational simplification. The impact of commodity cost volatility and continued investment in brand innovation will also be critical to monitor.

Edgewell Personal Care currently trades at $29.20, up from $28.53 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).

Our Favorite Stocks Right Now

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.